Sarada L Nandiwada
Overview
Explore the profile of Sarada L Nandiwada including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
404
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Nandiwada S, Tebo A
Clin Vaccine Immunol
. 2013 Feb;
20(4):447-51.
PMID: 23365209
Celiac disease (CD) is an autoimmune disorder that occurs in genetically susceptible individuals of all ages and is triggered by immune response to gluten and related proteins. The disease is...
12.
Martinez R, Zhang N, Thomas S, Nandiwada S, Jenkins M, Binstadt B, et al.
J Immunol
. 2011 Nov;
188(1):170-81.
PMID: 22124124
Rheumatoid arthritis develops in association with a defect in peripheral CD4(+) T cell homeostasis. T cell lymphopenia has also been shown to be a barrier to CD4(+) T cell clonal...
13.
Agarwal P, Raghavan A, Nandiwada S, Curtsinger J, Bohjanen P, Mueller D, et al.
J Immunol
. 2009 Jul;
183(3):1695-704.
PMID: 19592655
A third signal that can be provided by IL-12 or type I IFN is required for differentiation of naive CD8 T cells responding to Ag and costimulation. The cytokines program...
14.
Nandiwada S, Li W, Zhang R, Mueller D
J Immunol
. 2006 Jun;
177(1):401-13.
PMID: 16785536
During Ag stimulation of T cells, the recognition of B7 molecules by the CD28 costimulatory receptor increases the level of c-Fos, a component of the AP-1 transactivator known to bind...
15.
Vanasek T, Nandiwada S, Jenkins M, Mueller D
J Immunol
. 2006 May;
176(10):5880-9.
PMID: 16670295
T cell clonal anergy induction in lymphopenic nu/nu mice was found to be ineffective. Exposure to a tolerizing peptide Ag regimen instead induced aggressive CD4(+) cell cycle progression and increased...